Jing Qian

3PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Apr 05, 2024
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy.

Cassandra L Moyer, Amanda Lanier, Jing Qian

|Aug 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.

Abhijit Mazumdar, William M Tahaney, Jamal L Hill

Pageof 1